Cargando…
RANBP1, a member of the nuclear-cytoplasmic trafficking-regulator complex, is the terminal-striking point of the SGK1-dependent Th17(+) pathological differentiation
The Th17(+) arrangement is critical for orchestrating both innate and acquired immune responses. In this context, the serum and glucocorticoid regulated kinase 1 (SGK1) exerts a key role in the governance of IL-23R-dependent Th17(+) maturation, through the phosphorylation-dependent control of FOXO1...
Autores principales: | Brescia, Carolina, Dattilo, Vincenzo, D’Antona, Lucia, Chiarella, Emanuela, Tallerico, Rossana, Audia, Salvatore, Rocca, Valentina, Iuliano, Rodolfo, Trapasso, Francesco, Perrotti, Nicola, Amato, Rosario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333757/ https://www.ncbi.nlm.nih.gov/pubmed/37441077 http://dx.doi.org/10.3389/fimmu.2023.1213805 |
Ejemplares similares
-
RANBP1 (RAN Binding Protein 1): The Missing Genetic Piece in Cancer Pathophysiology and Other Complex Diseases
por: Audia, Salvatore, et al.
Publicado: (2023) -
SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation
por: Dattilo, Vincenzo, et al.
Publicado: (2017) -
In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity
por: D'Antona, Lucia, et al.
Publicado: (2019) -
Th17-Gene Expression Profile in Patients with Chronic Venous Disease and Venous Ulcers: Genetic Modulations and Preliminary Clinical Evidence
por: Amato, Rosario, et al.
Publicado: (2022) -
Kinase Inhibitors in Genetic Diseases
por: D’Antona, Lucia, et al.
Publicado: (2023)